Cargando…
What is the Need for Prostatic Biomarkers in Prostate Cancer Management?
Discriminating patients with a low risk of progression from those with lethal prostate cancer is one of the main challenges in prostate cancer management. Indeed, such discrimination is essential if we aim to avoid overtreatment in men with indolent disease and to improve survival in those men with...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534510/ https://www.ncbi.nlm.nih.gov/pubmed/26267226 http://dx.doi.org/10.1007/s11934-015-0545-3 |